The following items are related to Teva, our partner in the BIO-MIX project, as well as the fields of medical innovation and entrepreneurship, including biotech, Biomed, and more.
Bio-Mix is an entrepreneurial program created by Teva in collaboration with DigitalRosh, as part of Teva’s National Biotechnology Innovation Forum. Doctoral students and post-doctoral students from leading universities in Israel participate in the program and it is being held for the third year in a row. More than 100 male and female students participated in it.
The purpose of the program is to connect the laboratory and research to “real life” and to bridge the gap between an innovative idea from the field of medicine and biotechnology and a product or drug on the market.
Dr. Dana Bar-On
Senior director, director of academic relations, global research and development at Teva
BIO-MIX & Teva
Prof. Ronit Satchi Fainero: Nanomedicines and a 3D printed model
Prof. Ronit Sachi-Finero is researching the development of nanomedicines to select the appropriate treatment for cancer patients using 3D models
BioMix2022 תכנית של טבע ודיגיטלראש – מחזור שלישי
Bio-Mix היא תוכנית שנוצרה על ידי טבע יחד עםדיגיטלראש כחלק מהפורום לBio-Innovators עבור דוקטורנטים ופוסט-דוקטורנטים מאוניברסיטאות מובילות בישראל. ב-2022 החל
BioMix2022 Program of Teva and DigitalRosh – Third Round
Bio-Mix is a program created by Teva together with DigitalRosh as part of the Bio-Innovators Forum for doctoral students and
ד”ר ערן הררי – השתלבות בינה מלאכותית ולמידת מכונה בפיתוח תרופות
ד”ר ערן הררי, סמנכ”ל בכיר לתרופות מקור במו”פ הגלובלי של חברת טבע, הציג לנו את תחום מחקר ופיתוח של חברת
